|
Cell Applications Inc
bovine endothelial cell growth supplement ecgs Bovine Endothelial Cell Growth Supplement Ecgs, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/epi+data+statistical+package+social+software+version+21%2E0/Major+Media/pmc09027102-183-38-43 Average 96 stars, based on 1 article reviews
bovine endothelial cell growth supplement ecgs - by Bioz Stars,
2026-10
96/100 stars
|
Buy from Supplier |
|
Siemens AG
12-channel head coil 12 Channel Head Coil, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/epi+data+statistical+package+social+software+version+21%2E0/32+channel+head+coil/10__1007_slash_s10334___012___0324___9-4882-10-14 Average 90 stars, based on 1 article reviews
12-channel head coil - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
Addgene inc
tfpi β domain ![]() Tfpi β Domain, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/epi+data+statistical+package+social+software+version+21%2E0/MSX2-pET+(Plasmid+%2321025)/pmc09646764-423-34-17 Average 93 stars, based on 1 article reviews
tfpi β domain - by Bioz Stars,
2026-10
93/100 stars
|
Buy from Supplier |
|
Siemens AG
diffusion-weighted echo planar images (epi) ![]() Diffusion Weighted Echo Planar Images (Epi), supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/epi+data+statistical+package+social+software+version+21%2E0/multi+slice+diffusion+weighted+echo+planar+image/pm37993754-42-43-13 Average 90 stars, based on 1 article reviews
diffusion-weighted echo planar images (epi) - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
Callisto Pharmaceuticals
l-annamycin ![]() L Annamycin, supplied by Callisto Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/epi+data+statistical+package+social+software+version+21%2E0/liposomal+annamycin/10__1097_slash_01__cot__0000282482__94812__d1-4-88-92 Average 90 stars, based on 1 article reviews
l-annamycin - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
An impurity of Oxcarbazepine which is used to treat ertain types of seizures in patients with epilepsy.
|
Buy from Supplier |
|
Intermediate in the preparation of dibenzazepine derivatives.
|
Buy from Supplier |
|
16-Epiestriol-[d6] is a labelled metabolite of Estradiol. Estriol is one of the three main estrogens produced by the human body.
|
Buy from Supplier |
|
4-Epi Doxycycline is an alternative to doxycycline to control gene expression.
|
Buy from Supplier |
Image Search Results
Journal: Nature Communications
Article Title: Identification of TFPI as a receptor reveals recombination-driven receptor switching in Clostridioides difficile toxin B variants
doi: 10.1038/s41467-022-33964-9
Figure Lengend Snippet: a Schematic diagram of the CRISPR-Cas9 screen process. b Genes identified by NGS were analyzed with the MAGeCK program and plotted based on the log 2 value of fold change of NGS reads and statistical significance (shown as log 10 value of RRA p -value and plotted as the y -axis). The genes involved in the GPI (glycosylphosphatidylinositol) biosynthetic pathway are colored red. c Schematic diagram of human TFPIβ (TFPI), a GPI-anchored protein with two BPTI/Kunitz protease inhibitor domains (K1 and K2). N, N-termini; C, C-termini. HeLa ( d ) or A549 ( e ) KO cells lacking TFPI, TFPI2 (a homolog of TFPI), PIGS, or PIGV were generated via the CRISPR-Cas9 approach. UGP2-KO cells were also analyzed as a control. Cells were exposed to recombinant TcdB4.2 for 24 h. Their CR 50 values are normalized to WT and plotted in a bar-chart ( f ). Error bars indicate mean ± s.d.; N = 3 (biologically independent experiments); *, p < 0.05; **, p < 0.01 (Student’s t -test, two-sided). g – i HeLa ( g ) or 5637 ( h ) cells overexpressing triple-HA-tagged TFPI, TFPI2, or mouse TFPI (mTFPI) via lentiviral transduction were exposed to TcdB4.2 for 24 h. The percentages of rounded cells were plotted over toxin concentrations. Their CR 50 values are normalized to WT and plotted in a bar-chart ( i ). Error bars indicate mean ± s.d.; N = 3 (biologically independent experiments); **, p < 0.01 (Student’s t -test, two-sided). j Binding of TcdB4.2 (500 nM) to Fc-tagged TFPI, TFPI2, and mTFPI (immobilized onto capture biosensors) was examined using biolayer interferometry (BLI) assays. Fc-tagged extracellular domains of FZD2 (CRD2), SEMA6A, and IgG were used as controls. Representative sensorgrams from one of three independent experiments are shown. k HeLa cells were exposed to either TcdB4.2 alone (4 pM) or TcdB4.2 pre-incubated with Fc-tagged TFPI, TFPI2, or mTFPI at the indicated molar ratios (1:250 ~ 1:20,000) on ice for 1 h. The percentage of cell-rounding at 6 h incubation was plotted. Error bars indicate mean ± s.d.; N = 3 (biologically independent experiments); *, p < 0.05; **, p < 0.01 (Student’s t -test, two-sided). l HeLa-WT, TFPI-KO, and TFPI2-KO cells were exposed to recombinant TcdB2.1, TcdB7.2, TcdB12.1, TcsL, or culture supernatants of C. difficile strains expressing TcdB10.1 or TcdB11.2 for 24 h. The percentages of rounded cells were plotted over toxin concentrations are shown in Supplementary Fig. . Their CR 50 values were normalized to WT and plotted here. Error bars indicate mean ± s.d.; N = 3 (biologically independent experiments). m – p HeLa-WT, two CSPG4 KO single clones (CSPG4#1 and CSPG4#8), and two CSPG4/TFPI double KO cells (CSPG4#1-TFPI-KO and CSPG4#8-TFPI-KO) were exposed to TcdB4.2 ( m ), TcdB2.1 ( n ), or TcdB2.2 ( o ) for 24 h. The percentages of rounded cells were plotted over toxin concentrations. Their relative CR 50 values are plotted in a bar-chart ( p ). Error bars indicate mean ± s.d.; N = 3 (biologically independent experiments); **, p < 0.01 (Student’s t -test, two-sided). q HeLa cells overexpressing HA-tagged TFPI, TFPI2, or mTFPI via lentiviral transduction were exposed to recombinant TcdB2.1, TcdB2.2, TcdB7.2, TcdB12.1, TcsL, or culture supernatants of C. difficile strains expressingTcdB10.1 or TcdB11.2 for 24 h. The percentages of rounded cells were plotted over toxin concentrations and are shown in Supplementary Fig. . Their CR 50 values are normalized to WT and plotted here. Error bars indicate mean ± s.d.; N = 3 (biologically independent experiments); **, p < 0.01 (Student’s t -test, two-sided). Source data are provided as a Source Data file.
Article Snippet: TFPI (residues 29-209), TFPI2 (residues 23–235), and mouse TFPI (residues 29–217) were cloned into the pLenti-Hygro vector (
Techniques: CRISPR, Protease Inhibitor, Generated, Control, Recombinant, Transduction, Binding Assay, Incubation, Expressing, Clone Assay
Journal: Nature Communications
Article Title: Identification of TFPI as a receptor reveals recombination-driven receptor switching in Clostridioides difficile toxin B variants
doi: 10.1038/s41467-022-33964-9
Figure Lengend Snippet: a Schematic diagrams of TcdB4.2, TcdB4.2 1286–1805 , TcdB4.2 1835–2367 , TcdB1.1-FBD. TcdB4.1(B1.1) and TcdB1.1(B4.2) represent two mutant fragments exchanging 29 residues in the region 1432– 1600 that differ between TcdB4.1 and TcdB1.1. The numbers indicate the position of amino acid residues. GTD, glucosyltransferase domain; CPD, cysteine protease domain; DRBD, delivery/receptor-binding domain; CROPs, combined repetitive oligopeptides. Binding of 500 nM TcdB4.2 1286– 1805 ( b ) or TcdB4.2 1835– 2367 ( c ) to Fc-tagged TFPI and mTFPI was examined using BLI assays. Fc-tagged TFPI2, CRD2, SEMA6A, and IgG were used as controls. Representative sensorgrams from one of three independent experiments are shown. d HeLa cells transiently transfected with TFPI, TFPI2, mTFPI, SEMA6A, or FZD2 were exposed to FLAG-tagged TcdB4.2 1286– 1805 (5 µg/mL) on ice for 60 min, washed, fixed, permeabilized, and subjected to immunostaining analysis. Expression of exogenous proteins was confirmed by detecting fused HA or 1D4 tag. Nuclei were labeled with DAPI (blue). Scale bar, 5 µm. Representative images were from one of three independent experiments. Binding of 500 nM TcdB1.1-FBD, TcdB4.2 1286– 1805 , TcdB4.2(B1.1), and TcdB1.1(B4.2) to Fc-tagged CRD2 ( e ) and TFPI ( f ) was examined using BLI assays. Representative sensorgrams from one of three independent experiments are shown. g Schematic diagram of TFPIβ, TFPI-K1, and TFPI-K2 fragments. Sig, signal peptide; N, N-terminal domain; K1, BPTI/Kunitz inhibitor domain 1; L1, loop 1; K2, BPTI/Kunitz inhibitor domain 2; L2, loop 2; β, GPI anchor sequence for TFPIβ. h Binding of 500 nM TcdB4.2 1286-1805 to Fc-tagged TFPI, TFPI-K1, and TFPI-K2 was examined using BLI assays. Representative sensorgrams from one of three independent experiments are shown. i , j TcdB4.2 binding to TFPI-K2 prevents TFPI-K2 binding to its natural ligand coagulation factor Xa (FXa). FXa (0.5 ng/mL) cleaves its fluorescently labeled substrate and generates increasing fluorescent signal (measured as relative light unit, RLU, y -axis) over time ( x -axis). FXa’s enzymatic activity was inhibited by TFPI-K2 ( i , 7.5 ng/mL). The inhibitory effect of TFPI was blocked by adding TcdB4.2 1286– 1805 in a dose-dependent manner (1:1, 1:3, or 1:10 molar ratio). Representative curve from one of three independent experiments is shown. FXa activity was quantified by measuring the slope of RLU curves (1–10 min) and plotted as a bar-chart ( j ). The same experiments were also carried out for TFPI-Fc and mTFPI-Fc, with their curves shown in Supplementary Fig. and quantification in ( j ). Error bars indicate mean ± s.d.; N = 3; *, p < 0.05; **, p < 0.01 (Student’s t -test, two-sided). Source data are provided as a Source Data file.
Article Snippet: TFPI (residues 29-209), TFPI2 (residues 23–235), and mouse TFPI (residues 29–217) were cloned into the pLenti-Hygro vector (
Techniques: Mutagenesis, Binding Assay, Transfection, Immunostaining, Expressing, Labeling, Sequencing, Coagulation, Activity Assay
Journal: Nature Communications
Article Title: Identification of TFPI as a receptor reveals recombination-driven receptor switching in Clostridioides difficile toxin B variants
doi: 10.1038/s41467-022-33964-9
Figure Lengend Snippet: a Cultured undifferentiated human enteroids (in growth medium), differentiated human rectoids (in differentiation medium), and mouse intestinal organoids were exposed to either TcdB4.2 alone (10 pM) or TcdB4.2 pre-incubated with Fc-tagged TFPI, TFPI2, or mTFPI (100 nM) for 8 h. PBS was used as control (Ctrl). Stars indicate the dissociated organoids with released luminal contents; arrows indicate shrunken organoids; scale bar, 50 µm. Representative images are from one of three independent experiments. b Experiments were carried out as described in panel ( a ). After exposure to toxin for 3 days, cell viability was measured using the MTT assay and plotted as a bar-chart. Error bars indicate ± s.d.; N = 3 (biologically independent experiments); *, p < 0.05; **, p < 0.01 (Student’s t -test, two-sided). c , d Accumulation of fluid in the thoracic cavity occurred within 15 h after intraperitoneal injection of TcdB4.2 into mice (50 ng per 25 g bodyweight). Injection of TcdB4.2 pre-incubated with Fc-tagged TFPI or mTFPI at 1:2000 molar ratios showed less fluid accumulation. Co-injection of TcdB4.2 with Fc-tagged TFPI2 at 1:2000 molar ratio did not affect fluid accumulation. Injection of saline was included as a control. The range of boxes indicates ± s.e.m.; whiskers indicate ± s.d.; percentiles indicate median; **, p < 0.01 (Student’s t -test, two-sided). e Experiments were carried out as described in panel ( c ) and the edema in lung tissues was evaluated by calculating dry-to-wet weight ratios. TcdB4.2 reduced dry-to-wet weight ratio of lung tissue more than in the saline group. Co-injection of TcdB4.2 with TFPI-Fc or mTFPI-Fc prevented this reduction, whereas co-injection with TFPI2-Fc showed no protection from TcdB4.2. The range of boxes indicates ± s.e.m.; whiskers indicate ± s.d.; percentiles indicate median; *, p < 0.05; **, p < 0.01 (Student’s t -test, two-sided). f , g The sensitivity of HUVECs transfected with siRNAs targeting TFPI to TcdB1.1 or TcdB4.2 was analyzed using the 24 h cell-rounding assay. HUVECs transfected with non-targeting scrambled siRNAs served as a control. Dose-response curves are plotted in ( f ), and their relative CR 50 are plotted in a bar chart ( g ). Error bars indicate ± s.d.; N = 3 (biologically independent experiments); **, p < 0.01; NS not significant (Student’s t -test, two-sided). Source data are provided as a Source Data file.
Article Snippet: TFPI (residues 29-209), TFPI2 (residues 23–235), and mouse TFPI (residues 29–217) were cloned into the pLenti-Hygro vector (
Techniques: Cell Culture, Incubation, Control, MTT Assay, Injection, Saline, Transfection
Journal: Nature Communications
Article Title: Identification of TFPI as a receptor reveals recombination-driven receptor switching in Clostridioides difficile toxin B variants
doi: 10.1038/s41467-022-33964-9
Figure Lengend Snippet: a Amino acids across all 206 known TcdB sequences and 6 TcsL sequences were aligned and visualized using a haplotype coloring algorithm we recently developed , showing variation patterns across TcdB members. The first sequence (TcdB1.1) is assigned black color, and all other sequences colored black if they share the same residues. Unique residues in the second sequence (TcdB2.1) are colored green, followed by unique residues in the third sequence (TcdB4.2) colored red. The region 1460 to 1626 is enlarged for TcdB2/4/7 members. A unique B4/B7-haplotype can be visualized with residues in red color, with their position marked. Residue A1518 is unique in TcdB7 members and is colored gray. b The sequences of TcdB2.11, TcdB2.22, TcdB7.2, and TcdB7.5 were analyzed using a sliding window comparison with TcdB1.1, 2.1, 4.2, and 7.1, revealing their recombination patterns. Below each sliding window plot is a graphical summary depicting the recombination pattern. The location surrounding the TFPI/FZD-binding site (specificity-determining region) is marked. HeLa-WT, TFPI-KO, and TFPI2-KO cells were exposed to recombinant TcdB7.1 ( c ) or the culture supernatant of C. difficile strain expressing TcdB7.9 ( d ) for 24 h. The percentages of round-shaped cells were plotted over toxin or supernatant dilutions. Their CR values are normalized to WT and plotted in a bar-chart ( e ). Error bars indicate mean ± s.d.; N = 3 (biologically independent experiments); **, p < 0.01 (Student’s t -test, two-sided). HeLa cells overexpressing HA-tagged TFPI, TFPI2, or mTFPI via lentiviral transduction were exposed to recombinant TcdB7.1 ( f ) or the culture supernatant of C. difficile strain expressing TcdB7.9 ( g ) for 24 h. The percentages of round-shaped cells were plotted over toxin or supernatant dilutions. Their CR values were normalized to WT and plotted in a bar-chart ( h ). Error bars indicate mean ± s.d.; N = 3 (biologically independent experiments); **, p < 0.01 (Student’s t -test, two-sided). Source data are provided as a Source Data file.
Article Snippet: TFPI (residues 29-209), TFPI2 (residues 23–235), and mouse TFPI (residues 29–217) were cloned into the pLenti-Hygro vector (
Techniques: Sequencing, Residue, Comparison, Binding Assay, Recombinant, Expressing, Transduction
Journal: Nature Communications
Article Title: Identification of TFPI as a receptor reveals recombination-driven receptor switching in Clostridioides difficile toxin B variants
doi: 10.1038/s41467-022-33964-9
Figure Lengend Snippet: Binding of 500 nM TcdB1.1-FBD, TcdB2.1 1285– 1804 , TcdB2.11 1286– 1805 , TcdB4.2 1286– 1805 , TcdB7.2 1286– 1805 , TcdB7.5 1286– 1805 , TcdB10.1 1285– 1804 , TcdB11.2 1285– 1804 , TcdB12.1 1285– 1804 , and TcsL 1285– 1804 to Fc-tagged TFPI ( a ), mTFPI ( b ), or CRD2 ( c ) was examined using BLI assays. Representative sensorgrams from one of three independent experiments are shown. d , e HeLa-WT, FZD1/2/7-KO, CSPG4-KO, and UGP2-KO cells were exposed to the culture supernatant of a C. difficile strain expressing TcdB2.22 for 24 h. The percentages of round-shaped cells were plotted over supernatant dilution ( d ). The relative CR 50 values in different cell lines were normalized to the WT and plotted as a bar-chart ( e ). Error bars indicate mean ± s.d.; N = 3 (biologically independent experiments); *, p < 0.05; **, p < 0.01 (Student’s t -test, two-sided). f , g HeLa-WT, TFPI-KO, and TFPI2-KO cells were exposed to the culture supernatant of a C. difficile strain expressing TcdB2.22 for 24 h. The percentages of round-shaped cells were plotted over supernatant dilutions ( f ). The relative CR50 values in different cell lines were normalized to the WT and plotted as bar-chart ( g ). Error bars indicate mean ± s.d.; N = 3 (biologically independent experiments). h There are six residues that are different between TFPI-binding TcdB4.2, 2.11, 7.9 versus TcdB2.1 and 7.2 (1495, 1505, 1509, 1547, 1596, and 1599, marked as MT site 1–6). Mutagenesis studies were performed to replace the indicated residues on TcdB2.1 1285-1804 with the corresponding residues found in TcdB4.2. The binding of the indicated mutant proteins (500 nM) to immobilized TFPI-Fc was analyzed using BLI assays. TcdB2.11 1286– 1805 and TcdB2.1 1285– 1804 were analyzed as controls. Representative sensorgrams from one of three independent experiments are shown. i – k A TcdB1.1-FBD-5M mutant proteins were generated by replacing five residues in TcdB1.1 with the corresponding residues found in TcdB4.2 (positions 1495, 1505, 1547, 1596, and 1599). The binding of this mutant protein to immobilized TFPI-Fc ( i ), mTFPI-Fc ( j ), and CRD2 ( k ) was analyzed using BLI assays. TcdB1.1-FBD and TcdB4.2 1285– 1804 were analyzed as controls. Source data are provided as a Source Data file.
Article Snippet: TFPI (residues 29-209), TFPI2 (residues 23–235), and mouse TFPI (residues 29–217) were cloned into the pLenti-Hygro vector (
Techniques: Binding Assay, Expressing, Mutagenesis, Generated
Journal: Nature Communications
Article Title: Identification of TFPI as a receptor reveals recombination-driven receptor switching in Clostridioides difficile toxin B variants
doi: 10.1038/s41467-022-33964-9
Figure Lengend Snippet: Binding of 500 nM TcdB2.11 1286– 1805 ( a ), TcdB4.2 1286– 1805 ( b ), TcdB10.1 1285– 1804 ( c ), TcdB2.1 1285– 1804 ( d ), TcdB7.2 1286– 1805 ( e ), TcdB11.2 1285– 1804 ( f ), and TcdB12.1 1285– 1804 ( g ) to Fc-tagged TFPI from the indicated animal species was examined using BLI assays. Representative sensorgrams from one of two independent experiments are shown. h There are four different residues between TcdB10.1 1431– 1600 and TcdB11.2 1431– 1600 (1506, 1511, 1597, and 1598, marked as MT site 1–4). TcdB11.2 1285– 1804 mutant fragments were generated by replacing the residues at the indicated positions with the corresponding residues in TcdB10.1. Binding of 2000 nM TcdB10.1 1285-1804 , TcdB11.2 1285– 1804 , and TcdB11.2 1285– 1804 mutant fragments to Fc-tagged mTFPI was examined using BLI assays. Representative sensorgrams from one of three independent experiments are shown. i Plot of amino acid variation for key residues (B4/B7 haplotype and B10-specific substitutions) associated with gain of TFPI-binding in TcdB. A total of 212 sequences were clustered based on sequence identity into 12 distinct subtypes including two TcsL-related groups. A tree depicting these clusters is shown on the left, and on the right the associated residues are shown with gray indicating identity to the TcdB1.1 reference sequence. Variant residues from B1.1 are colored in shades of blue. j Surface conservation and variation of TcdB whereas the residues are colored according to their conservation across 206 distinct TcdB sequences. Structure of TcdB1-FZD-CRD2 complex (PDB: 6C0B ) was used for the surface presentation. CRD2 and the CDR-bound fatty acid (palmitoleic acid lipid, PAM) were shown as cartoon and spheres and colored as green and yellow, respectively. k The sequence diversified region that converged together at the FZD-binding site (receptor binding epitope) on TcdB1 were highlighted by a yellow dashed circle (upper panel). Six residues forming the B4/B7-haplotype were highlighted in yellow (middle panel) and four residues that are different TcdB10 and TcdB11 were highlighted in green (lower panel). l Structural location of key residues associated with gain of TFPI-binding is mapped on the structure of the TcdB1-FZD complex (PDB ID 6C0B ). The main FZD/TFPI-binding interface on TcdB1 that is composed of a α helix, a β sheet, and a long loop is colored orange, while the rest of the toxin is colored gray. B4/B7-haplotype and B10-specific substitutions are shown as blue and cyan sticks, respectively, while those overlapping with the FZD-binding residues are colored in pink. The rest of the FZD-binding residues on TcdB1 are colored red with their Cα atoms shown as small spheres and their side chains omitted for clarity.
Article Snippet: TFPI (residues 29-209), TFPI2 (residues 23–235), and mouse TFPI (residues 29–217) were cloned into the pLenti-Hygro vector (
Techniques: Binding Assay, Mutagenesis, Generated, Sequencing, Variant Assay